-logo.jpg "Kineta (Reverse Merger With Yumanity Therapeutics)"){kind=logo}
Kineta (Reverse Merger With Yumanity Therapeutics)
Pioneering new horizons in neurodegenerative disease treatment by addressing protein misfolding.
est. 2014
Wren Therapeutics
Stopping the wave of neurodegeneration at its source
34 employees · est. 2016 · Cambridge, United Kingdom
Kineta (Reverse Merger With Yumanity Therapeutics) is the older company (2014 vs 2016).
Side-by-Side Comparison
| Metric | Kineta (Reverse Merger With Yumanity Therapeutics) | Wren Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2016 |
| Headquarters | ||
| Headquarters | Not tracked yet | Cambridge, United Kingdom |
| Employees | ||
| Employees | Not tracked yet | 34 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series Unknown | Series Unknown |
| Total Funding | ||
| Total Funding | $137.36M | $30.40M |
| Funding Rounds | ||
| Funding Rounds | 4 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Neurodegenerative Diseases, Protein Misfolding, Drug Discovery, Therapeutics, Parkinson's Disease, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Biotech Industry, Neuroscience, Chemical Lead Series, Disease-modifying Therapies, Susan Lindquist, Tony Coles, Proprietary Platforms, Biomedical Research | Neurodegenerative Diseases, Biopharmaceutical Company, Drug Discovery, Protein Misfolding Diseases, Small-molecule Therapeutics, Parkinson's Disease, Alzheimer's Disease, ALS, Wren Therapeutics, Cambridge UK, New Technology Platform, Protein Intermediates, Oligomers, Rare Disorders, University Of Cambridge |
| Website | ||
| Website | yumanity.com | wrentherapeutics.com |
About Kineta (Reverse Merger With Yumanity Therapeutics)
Kineta is a biotechnology startup that recently completed a $33.60M Venture Round investment on 15 December 2020. This investment round saw participation from a diverse group of investors including Invus, Altium Capital, Fidelity, Ikarian Capital, Sphera Global Healthcare Fund, Stonepine Capital, an...
About Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company that has transformed drug discovery for neurodegenerative diseases through its platform, WaveBreak. This platform targets protein intermediates central to disease pathways, specifically focusing on the oligomers that are beyond the reach of convention...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Kineta (Reverse Merger With Yumanity Therapeutics) and Wren Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Kineta (Reverse Merger... and Wren Therapeutics — by email.
Frequently Asked Questions
Compare Kineta (Reverse Merger With Yumanity Therapeutics) with someone else
Start typing a company name or domain.